Minoxidil 5% topical
Most-studied OTC treatment for AGA. Apply 1mL solution or half-cap of foam twice daily on dry scalp. Effects at 4-6 months. Stop and the gains reverse in 3-6 months.
See Minoxidil 5% topical optionPersonalized treatment routing for androgenetic alopecia — the 90% case behind almost every receding hairline. Six questions, an evidence-graded stack out (minoxidil, finasteride, derma roller, telehealth or transplant), zero hype.
Norwood scale
The Norwood-Hamilton scale (1975) is the standard 7-stage map of male pattern baldness. Identifying your current stage is the single most useful diagnostic step, because the recommended treatment ladder branches sharply between Norwood 2-3 (preserve) and Norwood 4+ (preserve + restore).
No recession or slight, mature temple recession. Stable in most men. Lifestyle + preventive scalp care; medication only if there is a strong family history of aggressive loss.
Classic "M-shape" recession. Hair on top still mostly intact. This is the optimal window to start finasteride + minoxidil — preservation is far easier than restoration.
Recession plus visible crown/vertex thinning. Medication still works but expect smaller cosmetic gain. Begin considering transplant after 18-24 months of stabilization.
Progressive merger to horseshoe pattern. Medication maintains what remains; transplant restores within donor-area limits. Set expectations realistically — full density rarely achievable.
Look at yourself front-on and in side profile under good light. If your hairline still has a defined leading edge and the crown is intact, you are likely Norwood 2-3. If both temples have significantly receded AND the crown is visibly thinner under overhead light, you are Norwood 4 or beyond.
Treatment ladder
Ranked by evidence strength + reversibility. Most effective stacks combine multiple rungs — lifestyle + topical minoxidil + finasteride + derma roller is the textbook AGA protocol.
Most-studied OTC treatment for AGA. Apply 1mL solution or half-cap of foam twice daily on dry scalp. Effects at 4-6 months. Stop and the gains reverse in 3-6 months.
See Minoxidil 5% topical optionSinclair 2017 showed low-dose oral minoxidil at 0.25-5mg/day is comparable or slightly superior to topical. Requires Rx — most telehealth services (Hims, Keeps, Numan) prescribe it for hair loss. Mild side effects: hypertrichosis, fluid retention, dizziness.
See Oral minoxidil (low-dose, Rx) option5-alpha-reductase inhibitor. The most-studied AGA drug, FDA-approved since 1997. Side effects in RCTs: sexual dysfunction 1-4% (mostly reversible on discontinuation). Post-finasteride syndrome literature exists and is contested. Stack with minoxidil for the textbook AGA protocol. Not for women of reproductive age.
See Finasteride 1mg (oral, Rx) optionLee 2018 RCT: topical finasteride showed comparable hair counts to oral with about 50% less systemic absorption of finasteride. The compromise for users who want the efficacy but are concerned about sexual side effects. Compounded by some telehealth services (Hims, Keeps offer it).
See Topical finasteride optionInhibits BOTH type I and type II 5-alpha-reductase (finasteride only inhibits type II). Reduces DHT ~93% vs ~70% for finasteride. Stronger results but stronger side-effect profile too. Approved for hair loss in Korea and Japan; off-label elsewhere. Talk to a dermatologist before switching.
Dhurat 2013 RCT: minoxidil + microneedling 1x/week produced ~91% 'much better' improvement vs ~21% for minoxidil alone. The mechanism is wound-healing cascade releasing growth factors. Use 1.5mm (not 0.25mm), sterilize between uses, never on broken skin.
See Derma roller 1.5mm (microneedling) optionKetoconazole has shown modest anti-androgenic effects topically (Pierard-Franchimont 1998). Often included in serious stacks as a 2-3x/week wash. Treats coexisting seborrheic dermatitis (which itself accelerates shedding). Cheap, well-tolerated.
See Ketoconazole 2% shampoo (Nizoral) optionCentrifuged plasma re-injected into the scalp. Multiple small RCTs (Gupta 2017 meta-analysis) show modest improvement but heterogeneous protocols. Expensive, requires a clinic, and often used alongside (not instead of) minox+fin. Not first-line.
Follicular Unit Extraction (FUE) or Direct Hair Implant (DHI) moves donor follicles from non-AGA-sensitive zones (back of scalp) to bald areas. 90%+ graft survival, results visible at 9-12 months, permanent. Critical: medical maintenance (finasteride + minoxidil) MUST continue post-op, otherwise native hair around grafts continues to recede and the transplant looks isolated. Turkey clinics ($3-5k) dominate the market; quality varies wildly — research surgeons individually.
Address protein (1.2-1.5 g/kg), iron (ferritin >50 ng/mL especially for women), vitamin D, sleep. Daily 5-min scalp massage (Koyama 2016 small study) showed measurable density improvement at 24 weeks. Stop hot water, sulfate-heavy daily shampooing, tight hairstyles. Free baseline — does not replace medications for established AGA but multiplies their effect.
Telehealth services
Six legit AGA-focused telehealth platforms by region. All prescribe generic finasteride and minoxidil at far lower prices than retail pharmacies. Read the cancellation policy before signing up — most auto-renew on annual cadence.
The biggest US telehealth hair brand. Smooth onboarding, fair pricing.
Most-marketed US telehealth hair brand. Quick intake (no in-person visit), generic finasteride at the low end of the market, optional minoxidil bundle. Hair gummies in the upsell flow are biotin-heavy and largely cope — skip them. Strong shipping logistics, real US-licensed clinicians on file.
Hair-focused telehealth, owned by Thirty Madison.
More narrowly focused on hair than Hims. Comparable pricing on generic finasteride. Offers topical finasteride and Nizoral 2% (Rx-only in US) which Hims sometimes does not. Clinical content is solid and educational without aggressive upsell.
UK leader in men's telehealth. Hair loss + ED + testosterone.
Largest UK telehealth play for men's health. Covers AGA with finasteride and offers their own combined topical (finasteride + minoxidil). NHS-trained clinicians, GMC-regulated, decent customer service. The default if you are in the UK.
French telehealth for AGA. Local Rx, EU-compliant.
French telehealth platform offering AGA consultations with local physicians. Compliant with French medical regulations (which are stricter than US). Prescriptions filled by partner pharmacies; finasteride is available but requires a real medical conversation. Slower onboarding than Hims, more clinical.
UK men's wellness brand. Style-forward branding.
UK alternative to Numan with a more lifestyle-brand presentation. Comparable AGA offering (generic finasteride + minoxidil), heavier supplement upsell flow. If branding matters and you are in the UK, this is the option that does not feel like a medical site.
Turkey ($3-5k), Spain ($5-10k), US/UK ($10-20k). Quality > geography.
Hair-transplant pricing is dominated by geography (Turkey at the low end, Western Europe and US at the high end) but technique and surgeon experience matter far more than country. Research individual surgeons via the Hair Transplant Forum, review before/after portfolios at 12+ months, and verify the surgeon does the actual work (not just techs). Reputable surgeons are extremely transparent; clinics that obscure these details are red flags.
The honest test: count hairs from the daily shower drain or pillow for one week, and compare front-to-side scalp photos under the same lighting at 3-month intervals. Normal shedding is 50-100 hairs/day. Sustained >150/day is meaningful. Photos do not lie — selfies in your own bathroom under your own light, every 90 days, will tell you within a year. Anything sudden, patchy, or accompanied by scalp pain is NOT typical androgenetic alopecia and warrants a dermatologist visit before any treatment.
Norwood is the standard 7-stage classification for male pattern baldness. Stage 1 is no recession. Stage 2 is slight temple recession (very common, often stable). Stage 3 is the classic "M-shape" hairline. Stage 4 adds vertex/crown thinning. Stages 5-7 represent progressive merger of the two zones into a horseshoe pattern. Most treatment decisions branch at Norwood 2-3: this is the window where finasteride + minoxidil stop progression most effectively. Past Norwood 4, transplant becomes the only path to full restoration, but medication still stabilizes what remains.
Decades of RCT data: finasteride 1mg/day stops progression and modestly regrows hair in 80-90% of men with androgenetic alopecia at five-year follow-up. The trade-off is the side-effect profile: 1-4% incidence of sexual side effects (libido, erectile function, ejaculate volume) in trials, most reversible on discontinuation. Post-finasteride syndrome — persistent symptoms after stopping — exists in case reports but is contested in incidence. Honest take: if your hair matters to you and you understand the trade-off, finasteride is the most evidence-backed pharmacological tool that exists. If the side-effect risk is unacceptable, topical finasteride and oral minoxidil are reasonable alternatives.
Topical minoxidil 5% has the longest track record and is OTC. Sinclair 2017 demonstrated low-dose oral minoxidil (0.25-5mg/day) is comparable or slightly superior, with the major advantage of convenience (one pill vs twice-daily liquid). Oral has its own profile: hypertrichosis (extra body hair), occasional fluid retention, dizziness. It is off-label everywhere but Rx-prescribed by most major telehealth services (Hims, Keeps, Numan) as an off-label use. Most people now stack low-dose oral minox + finasteride and skip the topical.
For Norwood 4+ men with stable donor density and a realistic understanding of the limits, yes — FUE/DHI transplants have 90%+ graft survival and produce permanent results. Two conditions are non-negotiable: (1) the loss must be stabilized for 1-2 years before surgery (otherwise the surrounding native hair recedes around the grafts and the result looks isolated within 5 years), and (2) ongoing medical maintenance (finasteride + minoxidil) must continue post-op. Skipping either creates a worse outcome than no transplant. Turkey clinics dominate the global market at $3-5k; quality varies wildly — verify the surgeon does the actual work (not just techs), check 12+ month before-after portfolios.
The major telehealth platforms (Hims, Keeps, Roman, Numan, MOSS, Manual) are real licensed-clinician operations regulated by local medical boards. They prescribe identical-molecule generic finasteride and minoxidil at lower prices than retail pharmacies in most cases. Trade-offs: the consultations are async questionnaires (no in-person exam), which is fine for typical AGA but inadequate if your loss pattern is atypical. Most platforms auto-renew aggressively — read the cancellation policy before signing up. They are NOT a substitute for a dermatology consultation when something looks wrong.
Biotin: deficiency is rare; for non-deficient users, supplementation does nothing measurable. Saw palmetto: weak phytotherapy evidence (smaller effect than finasteride), worth a try only for users refusing pharmaceutical 5-AR inhibitors. Collagen: zero direct evidence for hair growth in non-deficient adults. Iron and vitamin D: real benefit IF you are deficient (especially women with hair shedding) — test first. Most "hair vitamin" subscriptions are profit-motivated bundles of common nutrients at fancy prices. Spend the money on minoxidil + finasteride or a derma roller — that is where the evidence sits.
Minoxidil: visible effect at 4-6 months, plateau by 12-18 months. Initial 4-8 week "shedding phase" is normal and predictive of response. Finasteride: stabilization at 3-6 months, modest regrowth visible at 6-12 months. Derma roller (paired with minox): adjunct effect at 4-6 months. Transplant: full result at 9-12 months post-op. Discontinuation: minoxidil gains reverse in 3-6 months, finasteride gains reverse in 6-12 months. These are not 4-week protocols — every single one of them is a multi-year commitment.
Partially. Female-pattern hair loss has different mechanisms (diffuse thinning, often hormonal) and different protocols. Minoxidil 5% topical is FDA-approved and works. Finasteride and dutasteride are NOT recommended for women of reproductive age (teratogenic — birth defect risk). Spironolactone is an oral anti-androgen sometimes prescribed off-label for women. Iron deficiency is a far more common cause of female hair loss than is AGA — get ferritin tested before any treatment. See a dermatologist familiar with female-pattern alopecia.
Always for: sudden hair loss (weeks not months), patchy or circular bald spots (possible alopecia areata or fungal infection), scalp pain or burning, hair loss with rash or scaling, hair loss in unusual patterns (no Norwood match), persistent shedding after a known stressor (illness, surgery, severe diet) for more than 12 months. Also if you are under 25 with aggressive Norwood 4+ pattern — that progression rate sometimes responds better to dutasteride than finasteride and benefits from in-person evaluation. Telehealth questionnaire flows do not catch atypical cases.
Biotin gummies for non-deficient users. "DHT-blocking shampoos" alone — DHT is produced systemically, rinse-off topicals barely engage. Hair growth supplements with proprietary blends. Laser caps (low-level light therapy): small inconsistent effects, expensive, adjunct at best. Castor oil daily as a regrowth therapy. PRP without underlying minox+fin. Anything promising regrowth on a fully bald scalp without surgery or proven medication. Stem-cell hair treatments outside of clinical trials. And the entire shadow market of unregulated "RU58841" / "CB-03-01" / "PP-405" research compounds — they exist but the safety data is non-existent.
This page is education, not medical advice. Hair loss has dozens of causes (AGA, telogen effluvium, alopecia areata, scarring alopecia, thyroid, iron deficiency, etc.). If you are losing hair quickly, in patches, or in unusual patterns, see a dermatologist BEFORE buying anything. Prescription medications (finasteride, dutasteride) carry side-effect profiles that require informed consent from a clinician.